Develops drugs for various diseases.
Jun 2026Revenue $49.2B/yrExpenses $37.3B/yr
No trend
Figures by year
Is Bristol Myers Squibb profitable?
Yes. In the 12 months to Jun 2026, revenue was $49.2B and expenses $37.3B.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2025 | $48.2B | $38.9B | $9.33B |
| Dec 2024 | $48.3B | $56.7B | −$8.38B |
| Dec 2023 | $45.0B | $36.6B | $8.44B |
| Dec 2022 | $46.2B | $38.4B | $7.71B |
| Dec 2021 | $46.4B | $38.3B | $8.10B |
| Dec 2020 | $42.5B | $49.4B | −$6.87B |
| Dec 2019 | $26.1B | $21.2B | $4.97B |
| Dec 2018 | $22.6B | $16.6B | $5.97B |
| Dec 2017 | $20.8B | $15.6B | $5.13B |
| Dec 2016 | $19.4B | $13.5B | $5.92B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.